The American Journal of Surgery
Volume 195, Issue 4 , Pages 457-462 , April 2008

Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer

Received 7 February 2007 ,Revised 5 June 2007

References 

  1. Bogdanova TI, Kozuritskii BG, Tronko ND. Thyroid Pathology in Children. Kiev: Chernobulinterinform; 2000;
  2. Yutan E, Clark O. Hurthle cell carcinoma. Curr Treat Options Oncol. 2001;2:331–335
  3. Grebe S, Hay I. Follicular thyroid cancer. Endocrinol Metab Clin North Am. 1995;24:761–801
  4. Shore RE. Issues and epidemiological evidence regarding radiation-induced thyroid cancer. Radiat Res. 1992;131:98–111
  5. Arganini M, Behar R, Wu T, et al. Hurthle cell tumors: a twenty-five-tear experience. Surgery. 1986;100:1108–1114
  6. Canzian F, Amati P, Harach H, et al. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet. 1998;63:1743–1748
  7. Sugino K, Koichi Ito, Mimura T, et al. Hurthle cell tumor of the thyroid: analysis of 188 cases. World J Surg. 2001;25:1160–1163
  8. Lopez-Penabad L, Chiu A, Hoff A, et al. Prognostic factors in patients with Hurthle cell neoplasms of the thyroid. Cancer. 2003;97:1186–1194
  9. Ruegemer J, Hay I, Bergstralh E, et al. Distant metastases in differentiated thyroid carcinoma. J Clin Endocrinol Metab. 1988;67:501–508
  10. Brennan MD, Bergstral EJ, van Heerden JA, McConahay WM. Follicular thyroid cancer treated at the Mayo Clinic, 1946-1970: initial manifestation, pathological findings, therapy and outcome. Mayo Clinic Proc. 1991;66:11–22
  11. Rosai J, Carcangiu M, Dellelis R. Atlas of Tumor Pathology (Tumor of the Thyroid gland). Bethesda, MD: Armed Forces Institute of Pathology; 1992;
  12. Herrera M, Hay J, Wu P, et al. Hurthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior. World J Surg. 1992;16:669–675
  13. Shaha A, Loree T, Shah J. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery. 1995;118:1131–1138
  14. McDonald M, Sanders L, Silverman M, et al. Hurthle cell carcinoma of the thyroid gland: prognostic factors and results of surgical treatment. Surgery. 1996;120:1000–1005
  15. Grant CS. Operative and postoperative management of the patients with follicular and Hurthle cell carcinoma: do they differ?. Surg Clin North Am. 1995;75:395–403
  16. DeGroot LJ, Kaplan EL, Shukla MS, et al. Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab. 1995;80:2946–2953
  17. Khafif A, Khafif R, Attie J. Hurthle cell carcinoma: a malignancy of low-grade potential. Head Neck. 1999;21:506–511
  18. Bhattacharyya N. Survival and prognosis in Hurthle cell carcinoma of the thyroid gland. Arch Otolaryngol Head Neck Surg. 2003;129:207–210
  19. Sanders L, Silverman M. Follicular and Hurthle cell carcinoma: predicting outcome and directing therapy. Surgery. 1998;124:967–974
  20. Evans H, Vassilopoulou-Sellin R. Follicular and Hurthle cell carcinoma of the thyroid (A comparative study). Am J Surg Pathol. 1998;22:1512–1520
  21. Kushchayeva Y, Duh QY, Kebebew E, Clark OH. Prognostic indications for Hurthle cell cancer. World J Surg. 2004;28:1266–1270
  22. D’Avanzo A, Treseler P, Ituarte P, et al. Follicular thyroid carcinoma: histology and prognosis. Cancer. 2004;1000:1123–1129
  23. Stojadinovic A, Hoos A, Ghossein R, et al. Hurthle cell carcinoma: a 60-years experience. Ann Surg Oncol. 2002;9:197–203
  24. Clark O, Gerand P. Thyrotropin receptor adenylate cyclase system in Hurthle cell neoplasms. J Clin Endocrinol Metab. 1985;61:773–778
  25. Chow S-M, Law KS, Mendenhall WM, et al. Follicular thyroid carcinoma (Prognostic factors and the role of radioiodine). Cancer. 2002;95:488–498
  26. Samaan N, Maheshwari Y, Nader S, et al. Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases. J Clin Endocrinol Metab. 1983;56:1131–1138
  27. Har-El G, Hadar T, Segal K, et al. Hurthle cell carcinoma of the thyroid gland (A tumor of moderate malignancy). Cancer. 1986;57:1613–1617
  28. De Groot LJ, Kaplan EL, Shukla MS, et al. Morbidity and mortality in follicular cancer. J Clin Endocrinol Metab. 1995;80:2946–2953
  29. Sherman SI, Brierley JD, Sperling M, et al. Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome (National Thyroid Cancer Treatment Cooperative Study Registry Group). Cancer. 1998;83:1012–1021
  30. Goldstein N, Czako P, Neill J. Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma: a study of 34 patients. Mod Pathol. 2001;13:123–130
  31. Mai K, Khanna P, Yazdi H, et al. Differentiated thyroid carcinoma with vascular invasion: a comparative study of follicular, Hurthle cell and papillary thyroid carcinoma. Pathology. 2002;34:239–244
  32. Thompson LD, Wieneke JA, Paal E, et al. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer. 2001;91:505–524
  33. McHenry C, Sandoval B. Management of follicular and Hurthle cell neoplasms of the thyroid gland. Surg Oncol Clin North Am. 1998;7:893–910
  34. Cooper S, Schneyer C. Follicular and Hurthle cell carcinoma of the thyroid. Endocrinol Metab Clin North Am. 1990;19:577–591
  35. Perrier N, Ituarte P, Treseler P, et al. Classification and treatment of follicular thyroid neoplasm are discordant between and within medical specialties. Surgery. 1999;126:1063–1069
  36. D’Avanzo A, Ituarte P, Treseler P, et al. Prognostic scoring system in patients with follicular cancer: a comparison of different staging system in predicting the patients outcome. Thyroid. 2004;14:453–458
  37. Emerick GT, Duh Q-Y, Sipersteine AE, et al. Diagnosis, treatment, and outcome of follicular thyroid carcinoma. Cancer. 1993;72:3287–3295
  38. Samaan NA, Schulttz PN, Hickey RC, et al. The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab. 1992;75:714–720
  39. Foote RL, Brown PD, Garces YI, et al. Is there a role for radiation therapy in the management of Hurthle cell carcinoma?. Int J Radiat Oncol Biol Phys. 2003;56:1067–1072
  40. Simpson WJ, Panzarella T, Carruthers JS, et al. Papillary and follicular thyroid cancer: impact of treatment in 1,578 patients. Int J Radiat Oncol Biol Phys. 1988;14:1063–1075

PII: S0002-9610(07)00450-3

doi: 10.1016/j.amjsurg.2007.06.001

The American Journal of Surgery
Volume 195, Issue 4 , Pages 457-462 , April 2008

Article Tools